46.46.Z - Wholesale trade of pharmaceutical and medical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
82.99.Z - Other business support activities, not elsewhere classified
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 8,8 | 5,2 | 6,1 | 18,6 |
EBITDA | 8,2 | 5,9 | 8,6 | 45,3 |
Short time liabilities | 33,1 | 16,4 | 10,4 | -36,4 |
Equity capital | 34,5 | 32,6 | 33,7 | 3,4 |
Operating profit (EBIT) | 8,1 | 5,8 | 8,5 | 46,2 |
Assets | 69,5 | 49,7 | 44,7 | -10,1 |
Net profit (loss) | 6,5 | 4,1 | 4,9 | 18,6 |
Cash | 4,5 | 20,7 | 6 | -71,2 |
Net income from sale | 281,6 | 209,3 | 222,5 | 6,3 |
Liabilities and provisions for liabilities | 35,1 | 17 | 10,9 | -35,8 |
Working assets | 57,8 | 37,7 | 33,5 | -11 |
Depreciation | 0,1 | 0,1 | 0,1 | 3,8 |
% | % | % | p.p. | |
Profitability of capital | 18,8 | 12,6 | 14,5 | 1,9 |
Equity capital to total assets | 49,6 | 65,7 | 75,5 | 9,8 |
Gross profit margin | 3,1 | 2,5 | 2,7 | 0,2 |
EBITDA Margin | 2,9 | 2,8 | 3,9 | 1,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 43 | 29 | 17 | -12 |
Current financial liquidity indicator | 1.6798479557037354 | 2.291438341140747 | 3.1806671619415283 | 0,9 |
Net dept to EBITDA | 2.154784917831421 | -2.8990697860717773 | -0.41988125443458557 | 2,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane